| Stage | SYK | % of rev | PDEX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.5B | 100.00% | $20M | 100.00% | SYK ×319.51 |
| Gross profit | $4.2B | 65.15% | $7M | 34.75% | SYK +30.4pp |
| Operating income | $1.0B | 15.86% | $4M | 17.29% | PDEX +1.4pp |
| Pre-tax income | $997M | 15.29% | $4M | 17.27% | PDEX +2.0pp |
| Net income | $753M | 11.55% | $3M | 14.00% | PDEX +2.5pp |
| Stage | SYK | PDEX | Gap · A − B |
|---|---|---|---|
| Revenue | $6.5B100.00% | $20M100.00% | SYK ×319.51 |
| Gross profit | 65.15%$4.2B | 34.75%$7M | SYK +30.4pp |
| Operating income | 15.86%$1.0B | 17.29%$4M | PDEX +1.4pp |
| Pre-tax income | 15.29%$997M | 17.27%$4M | PDEX +2.0pp |
| Net income |
| 11.55%$753M |
| 14.00%$3M |
| PDEX +2.5pp |
No shared counterparties.